9-Fluoro-2,3-Dihydro-10-(4-Methyl-1-Piperazinyl)-7-Oxo-7H-Pyrido(1,2,3-de)-1,4-Benzothiazine-6-Carboxylic Acid 1-Oxide Monohydrochlo ride
CAS: 132843-25-5
Ref. 3D-FF103798
| Tamaño no definido | A consultar |
Información del producto
- 9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid 1-oxide, monohydrochloride
- Rufloxacinsulfoxide
- 7H-Pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-, 1-oxide, monohydrochloride
- 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid 1-oxide hydrochloride (1:1)
9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H--pyrido(1,2,3-de)-1,4-benzothiazine--6--carboxylic acid 1 oxide monohydrochloride (9FDA) is a drug that has been used in pharmacokinetic studies in humans. It is administered as a single intravenous injection and has a half life of 12 hours. 9FDA is metabolized to 9FDAA and 9FDBA by the liver. The most abundant metabolites are found in urine after intravenous injections. The pharmacokinetics of this drug have been studied using high performance liquid chromatography with acetonitrile as the mobile phase. Constants were measured by injecting rhesus monkeys with 9FDA and measuring plasma concentrations over time using high performance liquid chromatography with an acetonitrile gradient
Propiedades químicas
Consulta técnica sobre: 3D-FF103798 9-Fluoro-2,3-Dihydro-10-(4-Methyl-1-Piperazinyl)-7-Oxo-7H-Pyrido(1,2,3-de)-1,4-Benzothiazine-6-Carboxylic Acid 1-Oxide Monohydrochlo ride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
